e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Present and future medical management of pulmonary arterial hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In pulmonary hypertension changes in right ventricular ejection fraction better predict mortality than changes in pulmonary vascular resistance
M. van de Veerdonk, J. Marcus, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
Source:
Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Session:
Present and future medical management of pulmonary arterial hypertension
Session type:
Oral Presentation
Number:
201
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. van de Veerdonk, J. Marcus, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands). In pulmonary hypertension changes in right ventricular ejection fraction better predict mortality than changes in pulmonary vascular resistance. Eur Respir J 2010; 36: Suppl. 54, 201
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
Contribution of increased afterload to right ventricular ejection fraction in pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Young males with pulmonary arterial hypertension have a high afterload and low right ventricular ejection fraction at presentation
Source: International Congress 2018 – On the right path: understanding and improving the function of an overloaded right heart ventricle
Year: 2018
Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 139-149
Year: 2015
Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 98s
Year: 2002
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019
Year: 2021
Increased right ventricular diastolic stiffness and reduced ejection fraction in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
Changes in right ventricular configuration between survivors and nonsurvivors in pulmonary arterial hypertension
Source: Annual Congress 2010 - Vascular and haemodynamics
Year: 2010
Changes in right ventricular mass are unrelated to changes in pulmonary pressures in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension
Source: Eur Respir J 2007; 29: 622-623
Year: 2007
Echocardiographic measures of right ventricular function poorly correlate with changes in contractility and coupling in treatment naïve patients with pulmonary artery hypertension before and after therapy.
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
Right ventricular size and contractile reserve significantly correlate in patients with pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Τhe influence of pulmonary disease on ventricular diastolic dysfunction in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002
Digoxin effect in mortality associated to right ventricular dysfunction in patients with pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Right ventricular systolic pressure as a prognostic factor for pulmonary hypertension with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept